Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Paediatric-onset lymphomatoid papulosis: results of a multicentre retrospective cohort study on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
Blanchard M, Morren MA, Busschots AM, Hauben E, Alberti-Violetti S, Berti E, Avallone G, Tavoletti G, Panzone M, Quaglino P, Colonna C, Melchers RC, Vermeer MH, Gniadecki R, Mitteldorf C, Gosmann J, Stadler R, Jonak C, Oren-Shabtai M, Hodak E, Friedland R, Gordon E, Geskin LJ, Scarisbrick JJ, Mayo Martínez F, Noguera Morel L, Pehr K, Amarov B, Faouzi M, Nicolay JP, Kempf W, Blanchard G, Guenova E. Blanchard M, et al. Among authors: hauben e. Br J Dermatol. 2024 Jul 16;191(2):233-242. doi: 10.1093/bjd/ljae150. Br J Dermatol. 2024. PMID: 38595050
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring.
Schrader AMR, de Groen RAL, Willemze R, Jansen PM, Quint KD, Cleven AHG, van Wezel T, van Eijk R, Ruano D, Veelken JHH, Tensen CP, Neelis KJ, Daniels LA, Hauben E, Woei-A-Jin FJSHS, Busschots AMA, Vermeer MH, Vermaat JSP. Schrader AMR, et al. Among authors: hauben e. Cancers (Basel). 2022 Oct 20;14(20):5152. doi: 10.3390/cancers14205152. Cancers (Basel). 2022. PMID: 36291936 Free PMC article.
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis.
Kemps PG, Woei-A-Jin FJSH, Quint KD, van den Bos C, Naeije L, van Laar JA, Vanden Bempt I, Koudijs MJ, Vorderman RHP, Stelloo E, Swennenhuis JF, Bruggink AH, Hebeda KM, Scheijde-Vermeulen MA, Diercks GF, Verdijk RM, Jansen PM, Hauben E, Tousseyn T, Cleven AH, van Wezel T, van Halteren AGS, Hogendoorn PCW. Kemps PG, et al. Among authors: hauben e. Blood Adv. 2024 Sep 24:bloodadvances.2024013696. doi: 10.1182/bloodadvances.2024013696. Online ahead of print. Blood Adv. 2024. PMID: 39361730 No abstract available.
Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study.
Freiberger SN, Ikenberg K, van Egmond D, Claerhout S, van Wezel T, Bempt IV, van Rossem JN, Mueller SA, Clement PM, Poorten VV, Cohen D, Hauben E, Rupp NJ. Freiberger SN, et al. Among authors: hauben e. Cancer Cytopathol. 2024 Jul;132(7):435-446. doi: 10.1002/cncy.22814. Epub 2024 Apr 2. Cancer Cytopathol. 2024. PMID: 38563876
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy.
Franken A, Bila M, Mechels A, Kint S, Van Dessel J, Pomella V, Vanuytven S, Philips G, Bricard O, Xiong J, Boeckx B, Hatse S, Van Brussel T, Schepers R, Van Aerde C, Geurs S, Vandecaveye V, Hauben E, Vander Poorten V, Verbandt S, Vandereyken K, Qian J, Tejpar S, Voet T, Clement PM, Lambrechts D. Franken A, et al. Among authors: hauben e. Immunity. 2024 Mar 12;57(3):541-558.e7. doi: 10.1016/j.immuni.2024.02.007. Epub 2024 Mar 4. Immunity. 2024. PMID: 38442708
Staging of colorectal cancer using lipid biomarkers and machine learning.
Krishnan ST, Winkler D, Creek D, Anderson D, Kirana C, Maddern GJ, Fenix K, Hauben E, Rudd D, Voelcker NH. Krishnan ST, et al. Among authors: hauben e. Metabolomics. 2023 Sep 20;19(10):84. doi: 10.1007/s11306-023-02049-z. Metabolomics. 2023. PMID: 37731020 Free PMC article.
The predictive and prognostic value of weight loss and body composition prior to and during immune checkpoint inhibition in recurrent or metastatic head and neck cancer patients.
Willemsen ACH, De Moor N, Van Dessel J, Baijens LWJ, Bila M, Hauben E, van den Hout MFCM, Vander Poorten V, Hoeben A, Clement PM, Schols AMWJ. Willemsen ACH, et al. Among authors: hauben e. Cancer Med. 2023 Apr;12(7):7699-7712. doi: 10.1002/cam4.5522. Epub 2022 Dec 9. Cancer Med. 2023. PMID: 36484469 Free PMC article.
138 results